The University of Colorado Cancer Center (UCCC) is organized into 6 research programs, each headed by two co-leaders chosen from consortium institutions. The co-leadership structure was instituted in order to bring more scientifically and geographically comprehensive and complementary oversight and management to the programs. This has also nurtured growth of several internal research foci that have now emerged as potentially new individual research programs. The leadership of the programs is as follows: Robert Sclafani, PhD and Dennis Roop, PhD in Cancer Cell Biology;Al Marcus, PhD and Raj Agarwal, PhD in Cancer Prevention and Control;S. Gail Eckhardt, MD and Wells Messersmith, MD in Developmental Therapeutics;M. Scott Lucia, MD and Heide Ford, PhD in Hormone-related Malignancies;York E. Miller, MD and Xiao- Jing Wang, PhD in Lung, Head &Neck;and James DeGregori, PhD and Joaquin Espinosa, PhD in Molecular Oncology. These twelve exceptional leaders are experts in their respective fields, which include the basic, clinical, and population sciences. Each co-leader brings individual research strengths that complement those of his/her respective co-leader, and both share the management responsibilities of research program leadership. Program leaders serve on the Cancer Center's Governance Committee and on other specific management, operational, and ad hoc committees where their particular talents and expertise is valued and used in programmatic decisions. These UCCC responsibilities include review of shared resource performance and needs, input on recruitments, review of membership, evaluation of seminars, symposia and communications, and participation in planning and evaluation activities including program retreats and genesis of the Strategic Plan. The program co-leaders are responsible for the activities within their own programs that include: 1) educational activities;2) new members and recruitments;3) mentoring of junior faculty;4) fostering collaborative and interdisciplinary research;5) planning and evaluating new and existing shared resources and 6) preparing reports. The educational activities include seminars and symposia including the Center-wide symposia, retreats, poster sessions, training programs, and standard and special courses in the various schools and consortium institutions. All new members have their applications proceed through program leadership to understand the scope of the cancer research and foster new collaborations. Program leaders both mentor young member and also suggest appropriate senior members mentors and steer new members to pilot projects and other grant opportunities.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
United States
Zip Code
Saichaemchan, S; Ariyawutyakorn, W; Varella-Garcia, M (2016) Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy. Curr Mol Med 16:40-62
Gillen, Austin E; Yamamoto, Tomomi M; Kline, Enos et al. (2016) Improvements to the HITS-CLIP protocol eliminate widespread mispriming artifacts. BMC Genomics 17:338
Justice, Cristina M; Bishop, Kevin; Carrington, Blake et al. (2016) Evaluation of IRX Genes and Conserved Noncoding Elements in a Region on 5p13.3 Linked to Families with Familial Idiopathic Scoliosis and Kyphosis. G3 (Bethesda) 6:1707-12
Eckwahl, Matthew J; Arnion, Helene; Kharytonchyk, Siarhei et al. (2016) Analysis of the human immunodeficiency virus-1 RNA packageome. RNA 22:1228-38
Iguchi, Nao; Malykhina, Anna P; Wilcox, Duncan T (2016) Inhibition of HIF Reduces Bladder Hypertrophy and Improves Bladder Function in Murine Model of Partial Bladder Outlet Obstruction. J Urol 195:1250-6
Seedorf, Gregory; Metoxen, Alexander J; Rock, Robert et al. (2016) Hepatocyte growth factor as a downstream mediator of vascular endothelial growth factor-dependent preservation of growth in the developing lung. Am J Physiol Lung Cell Mol Physiol 310:L1098-110
Agarwal, Neeraj; Dancik, Garrett M; Goodspeed, Andrew et al. (2016) GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis. Cancer Res 76:5175-85
Helfrich, Barbara A; Kim, Jihye; Gao, Dexiang et al. (2016) Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. Mol Cancer Ther 15:2314-2322
Munson, Daniel J; Egelston, Colt A; Chiotti, Kami E et al. (2016) Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR. Proc Natl Acad Sci U S A 113:8272-7
Scott, Aaron J; Lieu, Christopher H; Messersmith, Wells A (2016) Therapeutic Approaches to RAS Mutation. Cancer J 22:165-74

Showing the most recent 10 out of 1302 publications